The use of dual antiplatelet therapy for ischemic cerebrovascular events

In the last 10 years, the use of dual antiplatelet therapy (DAPT) in the neurological ambit has been explored in patients with non-cardioembolic ischemic stroke, transient ischemic attack (TIA), and intracranial atherosclerotic disease. Two clinical trials (CHANCE and POINT) showed that in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mele, Francesco, Gendarini, Claudia, Pantoni, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816218/
https://www.ncbi.nlm.nih.gov/pubmed/36114982
http://dx.doi.org/10.1007/s10072-022-06395-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816218/
https://www.ncbi.nlm.nih.gov/pubmed/36114982
http://dx.doi.org/10.1007/s10072-022-06395-z

Ejemplares similares